Michael T. Yin, MD

Co-Director, Biobehavioral Core of the HIV Center for Clinical and Behavioral Studies
Associate Professor of Medicine, Columbia University Medical Center

Email: mty4@cumc.columbia.edu

Michael Yin, MD, is an Associate Professor of Medicine at Columbia University Medical Center, and both a clinical provider and researcher. His research is focused upon the optimization of HIV treatment and care. He examined the epidemiology and pathogenic mechanisms of HIV associated bone loss postmenopausal women and
adolescents utilizing novel imaging techniques, markers of immune activation, and translational bone cell assays to investigate dysregulation of bone metabolism associated with HIV infection and ART. In current R01’s, he is evaluating the impact effect of inflammation and ART on bone mass and structure in perinatally HIV-infected children in South Africa and the effect of oral immune activation on periodontal health and
alveolar bone loss in HIV-infected women. Dr. Yin is also an active investigator in AIDS Clinical Trials Group (ACTG), the HIV Vaccine Trials Network (HVTN) and a co-investigator on the NIH-funded program grant, Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit (CTU).


Princeton University, New Jersey
BA - English - 1991

Columbia University College of Physicians and Surgeons,
MD – 1996

Mailman School of Public Health, Columbia University
MS- Epidemiology - 2004